Google Alert - hepatitis c

[Guest guest]

News

10 new results for hepatitis c

Both Sides Point Fingers in Opening Statements at Hep C TrialKLAS-TVBy Drawhorn, Reporter - email LAS VEGAS -- A second trial in the hepatitis C outbreak is underway at the Regional Justice Center. A jury must decide whether drug companies are responsible for patients contracting the incurable liver disease at ...See all stories on this topic »

Could Vertex Sell $1 Billion Of Its Hepatitis C Drug This Year?ForbesVertex Pharmaceuticals has been going up against drug giant Merck in a marketing battle to treat hepatitis C — and so far it's winning in a big way. Despite a partnership with Roche, one of the traditional leaders in the hepatitis C market, ...See all stories on this topic »

Teva's second hep C lawsuit goes to trialFiercePharmaTeva Pharmaceutical Industries ($TEVA) is in court this week, fighting its second lawsuit claiming that anesthetic vials sold by the company caused patients to develop hepatitis C. The company faces about 300 similar suits, one-third of which have been ...See all stories on this topic »

Same-Day Hepatitis C Testing Now Available from getSTDtested.comPrfire (press release)Hepatitis C is the most common bloodborne illness and may present as either an acute or chronic infection. Acute hepatitis C infections heal without medication; chronic infections may lead to long-term liver damage. The getSTDtested.com approach to ...See all stories on this topic »

Methylenetetrahydrofolate Reductase (MTHFR) C677T polymorphism and high plasma ...7thSpace Interactive (press release)We analyzed the frequency of MTHFR gene in a cross-sectional study of patients affected by Chronic Hepatitis C (CHC) from Northeast of Brazil. Method: One hundred seven-four untreated patients with CHC were

genotyped for the C677T MTHFR. ...See all stories on this topic »

Immunopathologic differences of Sjogren's syndrome versus sicca syndrome in ...7thSpace Interactive (press release)Among these conditions, chronic hepatitis C virus (HCV) infection, associated with mixed cryoglobulinaemia and extra-hepatic manifestations, and human immunodeficiency virus (HIV) infection, particularly in the phase of diffuse interstitial

lymphocytic ...See all stories on this topic »

Biotech Stock Mailbag: Idenix PharmaTheStreet.comIn my biotech hedge fund story Wednesday, I mentioned that ide Capital Management, a longtime backer of Vertex Pharmaceuticals(VRTX) and its hepatitis C drug Incivek, had also acquired a significant, 9 million-share position in Idenix ...See all stories on this topic »

Campaign promotes safe sexOtago Daily TimesBy Elspeth McLean on Sat, 20 Aug 2011 Public Health South sexual health promotion adviser Massey (left) and Hepatitis C Resource Centre educator and phlebotomist Heath Te Au display some of the material to be used in the Otago-Southland Rugby ...See all stories on this topic »

Otago Daily Times

New Rapid HIV, HCV Tests May Improve Point-of-Care TestingMedscapeResearchers are also working on developing an oral hepatitis C virus (HCV) test. The currently approved OraQuick ADVANCE Rapid HIV-1/2 Antibody Test detects antibodies to HIV-1 and HIV-2 in 20 minutes. The new test is designed to deliver results in 10 ...See all stories on this topic »

Vertex's Incivek could top $1B this year, analyst saysFiercePharmaVertex Pharmaceuticals ($VRTX) is galloping ahead with its hepatitis C drug Incivek. So fast, in fact, that at least one analyst thinks the breakthrough treatment could top $1 billion this year, Forbes reports. And that's with only 222 days on the ...See all stories on this topic »